209 related articles for article (PubMed ID: 9151831)
1. Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions.
Ono A; Huang M; Freed EO
J Virol; 1997 Jun; 71(6):4409-18. PubMed ID: 9151831
[TBL] [Abstract][Full Text] [Related]
2. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
Freed EO; Martin MA
J Virol; 1996 Jan; 70(1):341-51. PubMed ID: 8523546
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
4. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.
Kiernan RE; Ono A; Englund G; Freed EO
J Virol; 1998 May; 72(5):4116-26. PubMed ID: 9557701
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the conserved cysteine residues in the simian immunodeficiency virus matrix protein.
González SA; Affranchino JL
Virology; 1995 Jul; 210(2):501-7. PubMed ID: 7618287
[TBL] [Abstract][Full Text] [Related]
6. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix.
Freed EO; Martin MA
J Virol; 1995 Mar; 69(3):1984-9. PubMed ID: 7853546
[TBL] [Abstract][Full Text] [Related]
7. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.
Dorfman T; Mammano F; Haseltine WA; Göttlinger HG
J Virol; 1994 Mar; 68(3):1689-96. PubMed ID: 8107229
[TBL] [Abstract][Full Text] [Related]
8. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.
Yu X; Yuan X; Matsuda Z; Lee TH; Essex M
J Virol; 1992 Aug; 66(8):4966-71. PubMed ID: 1629961
[TBL] [Abstract][Full Text] [Related]
9. Identification of domains in the simian immunodeficiency virus matrix protein essential for assembly and envelope glycoprotein incorporation.
González SA; Burny A; Affranchino JL
J Virol; 1996 Sep; 70(9):6384-9. PubMed ID: 8709267
[TBL] [Abstract][Full Text] [Related]
10. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
Ono A; Orenstein JM; Freed EO
J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
[TBL] [Abstract][Full Text] [Related]
11. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis.
Mammano F; Ohagen A; Höglund S; Göttlinger HG
J Virol; 1994 Aug; 68(8):4927-36. PubMed ID: 8035491
[TBL] [Abstract][Full Text] [Related]
12. Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions.
Lopez-Vergès S; Camus G; Blot G; Beauvoir R; Benarous R; Berlioz-Torrent C
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14947-52. PubMed ID: 17003132
[TBL] [Abstract][Full Text] [Related]
13. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
Huang M; Orenstein JM; Martin MA; Freed EO
J Virol; 1995 Nov; 69(11):6810-8. PubMed ID: 7474093
[TBL] [Abstract][Full Text] [Related]
14. Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.
Kiernan RE; Ono A; Freed EO
J Virol; 1999 Jun; 73(6):4728-37. PubMed ID: 10233933
[TBL] [Abstract][Full Text] [Related]
15. Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly.
Lambelé M; Labrosse B; Roch E; Moreau A; Verrier B; Barin F; Roingeard P; Mammano F; Brand D
J Virol; 2007 Jan; 81(1):125-40. PubMed ID: 17050592
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes.
Lee YM; Tang XB; Cimakasky LM; Hildreth JE; Yu XF
J Virol; 1997 Feb; 71(2):1443-52. PubMed ID: 8995670
[TBL] [Abstract][Full Text] [Related]
17. Direct interaction between the envelope and matrix proteins of HIV-1.
Cosson P
EMBO J; 1996 Nov; 15(21):5783-8. PubMed ID: 8918455
[TBL] [Abstract][Full Text] [Related]
18. Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N terminus of the simian immunodeficiency virus matrix protein.
Manrique JM; Celma CC; Hunter E; Affranchino JL; González SA
J Virol; 2003 Oct; 77(20):10881-8. PubMed ID: 14512538
[TBL] [Abstract][Full Text] [Related]
19. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.
Murakami T; Freed EO
J Virol; 2000 Apr; 74(8):3548-54. PubMed ID: 10729129
[TBL] [Abstract][Full Text] [Related]
20. Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles.
González SA; Affranchino JL; Gelderblom HR; Burny A
Virology; 1993 Jun; 194(2):548-56. PubMed ID: 8503172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
